CN102488967B - 利用电场从不同方向治疗肿瘤等 - Google Patents
利用电场从不同方向治疗肿瘤等 Download PDFInfo
- Publication number
- CN102488967B CN102488967B CN201110226148.3A CN201110226148A CN102488967B CN 102488967 B CN102488967 B CN 102488967B CN 201110226148 A CN201110226148 A CN 201110226148A CN 102488967 B CN102488967 B CN 102488967B
- Authority
- CN
- China
- Prior art keywords
- field
- cell
- electrode
- electric field
- frequency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000005684 electric field Effects 0.000 title claims abstract description 146
- 206010028980 Neoplasm Diseases 0.000 title description 84
- 230000006378 damage Effects 0.000 claims abstract description 27
- 230000036541 health Effects 0.000 claims description 38
- 230000010363 phase shift Effects 0.000 claims description 11
- 230000012010 growth Effects 0.000 claims description 8
- 230000001629 suppression Effects 0.000 claims description 6
- 210000004027 cell Anatomy 0.000 abstract description 215
- 210000004881 tumor cell Anatomy 0.000 abstract description 18
- 230000032823 cell division Effects 0.000 abstract description 8
- 230000006872 improvement Effects 0.000 abstract description 2
- 230000031016 anaphase Effects 0.000 abstract 1
- 239000004020 conductor Substances 0.000 description 60
- 238000011282 treatment Methods 0.000 description 55
- 210000001519 tissue Anatomy 0.000 description 51
- 238000000034 method Methods 0.000 description 37
- 239000000499 gel Substances 0.000 description 33
- 230000000694 effects Effects 0.000 description 31
- 239000000463 material Substances 0.000 description 29
- 239000012212 insulator Substances 0.000 description 25
- 230000008859 change Effects 0.000 description 23
- 230000007246 mechanism Effects 0.000 description 23
- 238000009826 distribution Methods 0.000 description 21
- 239000010408 film Substances 0.000 description 21
- 210000000056 organ Anatomy 0.000 description 18
- 230000008569 process Effects 0.000 description 17
- 208000032612 Glial tumor Diseases 0.000 description 16
- 206010018338 Glioma Diseases 0.000 description 16
- 201000011510 cancer Diseases 0.000 description 16
- 238000010586 diagram Methods 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 210000000170 cell membrane Anatomy 0.000 description 14
- 238000009413 insulation Methods 0.000 description 14
- 239000000523 sample Substances 0.000 description 14
- 201000001441 melanoma Diseases 0.000 description 13
- 230000006698 induction Effects 0.000 description 12
- 150000002500 ions Chemical class 0.000 description 12
- 230000006870 function Effects 0.000 description 11
- 210000000481 breast Anatomy 0.000 description 10
- 230000004992 fission Effects 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 210000003463 organelle Anatomy 0.000 description 10
- 239000012528 membrane Substances 0.000 description 8
- 230000010287 polarization Effects 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000003990 capacitor Substances 0.000 description 7
- 230000004663 cell proliferation Effects 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 230000035515 penetration Effects 0.000 description 7
- 102000029749 Microtubule Human genes 0.000 description 6
- 108091022875 Microtubule Proteins 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 230000004888 barrier function Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 210000000349 chromosome Anatomy 0.000 description 6
- 239000003792 electrolyte Substances 0.000 description 6
- 210000003722 extracellular fluid Anatomy 0.000 description 6
- 230000009931 harmful effect Effects 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 210000004688 microtubule Anatomy 0.000 description 6
- 230000008520 organization Effects 0.000 description 6
- 230000005855 radiation Effects 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 230000000638 stimulation Effects 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 230000001086 cytosolic effect Effects 0.000 description 5
- 238000005868 electrolysis reaction Methods 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 231100000915 pathological change Toxicity 0.000 description 5
- 230000036285 pathological change Effects 0.000 description 5
- 238000001959 radiotherapy Methods 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 210000004718 centriole Anatomy 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 4
- 230000021953 cytokinesis Effects 0.000 description 4
- 210000000805 cytoplasm Anatomy 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 238000007917 intracranial administration Methods 0.000 description 4
- 230000002147 killing effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 230000002085 persistent effect Effects 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 241000195493 Cryptophyta Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 208000009956 adenocarcinoma Diseases 0.000 description 3
- 210000003169 central nervous system Anatomy 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000005611 electricity Effects 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 210000002977 intracellular fluid Anatomy 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000011278 mitosis Effects 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000002423 protozoacide Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000008093 supporting effect Effects 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 108091060290 Chromatid Proteins 0.000 description 2
- 208000036086 Chromosome Duplication Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000204031 Mycoplasma Species 0.000 description 2
- 206010029098 Neoplasm skin Diseases 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 201000008275 breast carcinoma Diseases 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 210000004756 chromatid Anatomy 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000013536 elastomeric material Substances 0.000 description 2
- 238000010292 electrical insulation Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000005294 ferromagnetic effect Effects 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000016507 interphase Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000010349 pulsation Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 208000037803 restenosis Diseases 0.000 description 2
- 230000001235 sensitizing effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 230000005619 thermoelectricity Effects 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- WSMQKESQZFQMFW-UHFFFAOYSA-N 5-methyl-pyrazole-3-carboxylic acid Chemical compound CC1=CC(C(O)=O)=NN1 WSMQKESQZFQMFW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 201000003076 Angiosarcoma Diseases 0.000 description 1
- 206010003571 Astrocytoma Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 229910004247 CaCu Inorganic materials 0.000 description 1
- 241000229175 Calotes Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 208000005243 Chondrosarcoma Diseases 0.000 description 1
- 201000009047 Chordoma Diseases 0.000 description 1
- 208000006332 Choriocarcinoma Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 208000009798 Craniopharyngioma Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 208000002699 Digestive System Neoplasms Diseases 0.000 description 1
- 201000009051 Embryonal Carcinoma Diseases 0.000 description 1
- 206010014967 Ependymoma Diseases 0.000 description 1
- 208000006168 Ewing Sarcoma Diseases 0.000 description 1
- 201000008808 Fibrosarcoma Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000001258 Hemangiosarcoma Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- 206010023330 Keloid scar Diseases 0.000 description 1
- 241000446313 Lamella Species 0.000 description 1
- 208000018142 Leiomyosarcoma Diseases 0.000 description 1
- 229910013641 LiNbO 3 Inorganic materials 0.000 description 1
- 206010025219 Lymphangioma Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 208000007054 Medullary Carcinoma Diseases 0.000 description 1
- 208000000172 Medulloblastoma Diseases 0.000 description 1
- 206010027406 Mesothelioma Diseases 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 201000010133 Oligodendroglioma Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 208000007641 Pinealoma Diseases 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 208000007452 Plasmacytoma Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000006265 Renal cell carcinoma Diseases 0.000 description 1
- 201000000582 Retinoblastoma Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010041067 Small cell lung cancer Diseases 0.000 description 1
- 206010041579 Spinal meningioma benign Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 208000014070 Vestibular schwannoma Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000004064 acoustic neuroma Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- VKJLWXGJGDEGSO-UHFFFAOYSA-N barium(2+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[Ti+4].[Ba+2] VKJLWXGJGDEGSO-UHFFFAOYSA-N 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 208000003362 bronchogenic carcinoma Diseases 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000002230 centromere Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 208000002445 cystadenocarcinoma Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000012777 electrically insulating material Substances 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229920001821 foam rubber Polymers 0.000 description 1
- 239000002223 garnet Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 201000002222 hemangioblastoma Diseases 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000007154 intracellular accumulation Effects 0.000 description 1
- MTRJKZUDDJZTLA-UHFFFAOYSA-N iron yttrium Chemical compound [Fe].[Y] MTRJKZUDDJZTLA-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 206010024627 liposarcoma Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000015534 lymphangioendothelioma Diseases 0.000 description 1
- 208000012804 lymphangiosarcoma Diseases 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 238000003913 materials processing Methods 0.000 description 1
- 208000023356 medullary thyroid gland carcinoma Diseases 0.000 description 1
- 206010027191 meningioma Diseases 0.000 description 1
- 230000006510 metastatic growth Effects 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 208000001611 myxosarcoma Diseases 0.000 description 1
- 208000018389 neoplasm of cerebral hemisphere Diseases 0.000 description 1
- 208000025189 neoplasm of testis Diseases 0.000 description 1
- 201000008026 nephroblastoma Diseases 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 201000010198 papillary carcinoma Diseases 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 210000002990 parathyroid gland Anatomy 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 208000024724 pineal body neoplasm Diseases 0.000 description 1
- 201000004123 pineal gland cancer Diseases 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 201000001514 prostate carcinoma Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- -1 rutile) is very high Chemical compound 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 201000008407 sebaceous adenocarcinoma Diseases 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 208000000587 small cell lung carcinoma Diseases 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 201000005565 spinal meningioma Diseases 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 206010042863 synovial sarcoma Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 230000002476 tumorcidal effect Effects 0.000 description 1
- 238000000539 two dimensional gel electrophoresis Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
Abstract
Description
Claims (8)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63987304P | 2004-12-27 | 2004-12-27 | |
US60/639,873 | 2004-12-27 | ||
CN200580048335XA CN101124011B (zh) | 2004-12-27 | 2005-12-27 | 利用电场从不同方向治疗肿瘤等 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200580048335XA Division CN101124011B (zh) | 2004-12-27 | 2005-12-27 | 利用电场从不同方向治疗肿瘤等 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102488967A CN102488967A (zh) | 2012-06-13 |
CN102488967B true CN102488967B (zh) | 2016-03-30 |
Family
ID=36791623
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200580048335XA Active CN101124011B (zh) | 2004-12-27 | 2005-12-27 | 利用电场从不同方向治疗肿瘤等 |
CN201110226148.3A Active CN102488967B (zh) | 2004-12-27 | 2005-12-27 | 利用电场从不同方向治疗肿瘤等 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200580048335XA Active CN101124011B (zh) | 2004-12-27 | 2005-12-27 | 利用电场从不同方向治疗肿瘤等 |
Country Status (6)
Country | Link |
---|---|
US (1) | US7565206B2 (zh) |
EP (2) | EP3666328B1 (zh) |
JP (1) | JP5559460B2 (zh) |
CN (2) | CN101124011B (zh) |
CA (1) | CA2594231C (zh) |
WO (1) | WO2006085150A2 (zh) |
Families Citing this family (133)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8447395B2 (en) * | 2000-02-17 | 2013-05-21 | Novocure Ltd | Treating bacteria with electric fields |
US7136699B2 (en) * | 2002-10-02 | 2006-11-14 | Standen, Ltd. | Apparatus for destroying dividing cells |
US7089054B2 (en) * | 2002-10-02 | 2006-08-08 | Standen Ltd. | Apparatus and method for treating a tumor or the like |
US7599746B2 (en) | 2000-02-17 | 2009-10-06 | Standen Ltd | Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases |
CN1416466A (zh) | 2000-02-17 | 2003-05-07 | 约朗姆·帕尔蒂 | 破坏正在分裂的细胞的方法和装置 |
US8175698B2 (en) | 2000-02-17 | 2012-05-08 | Novocure Ltd. | Treating bacteria with electric fields |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US20070135875A1 (en) | 2002-04-08 | 2007-06-14 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US7853333B2 (en) | 2002-04-08 | 2010-12-14 | Ardian, Inc. | Methods and apparatus for multi-vessel renal neuromodulation |
US8774922B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods |
US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
US20140018880A1 (en) | 2002-04-08 | 2014-01-16 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
US8774913B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravasculary-induced neuromodulation |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US8145317B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods for renal neuromodulation |
US9308043B2 (en) | 2002-04-08 | 2016-04-12 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
US20070129761A1 (en) | 2002-04-08 | 2007-06-07 | Ardian, Inc. | Methods for treating heart arrhythmia |
US8145316B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US6978174B2 (en) | 2002-04-08 | 2005-12-20 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US8175711B2 (en) | 2002-04-08 | 2012-05-08 | Ardian, Inc. | Methods for treating a condition or disease associated with cardio-renal function |
US9636174B2 (en) | 2002-04-08 | 2017-05-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
US7620451B2 (en) | 2005-12-29 | 2009-11-17 | Ardian, Inc. | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach |
US9308044B2 (en) | 2002-04-08 | 2016-04-12 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
US20080213331A1 (en) | 2002-04-08 | 2008-09-04 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US8131371B2 (en) * | 2002-04-08 | 2012-03-06 | Ardian, Inc. | Methods and apparatus for monopolar renal neuromodulation |
US7162303B2 (en) | 2002-04-08 | 2007-01-09 | Ardian, Inc. | Renal nerve stimulation method and apparatus for treatment of patients |
US20040082859A1 (en) | 2002-07-01 | 2004-04-29 | Alan Schaer | Method and apparatus employing ultrasound energy to treat body sphincters |
DE10260149A1 (de) * | 2002-12-20 | 2004-07-01 | BSH Bosch und Siemens Hausgeräte GmbH | Vorrichtung zur Bestimmung des Leitwertes von Wäsche, Wäschetrockner und Verfahren zur Verhinderung von Schichtbildung auf Elektroden |
RU2364329C2 (ru) * | 2003-01-27 | 2009-08-20 | Компьюмедикс Ю-Эс-Эй, Инк. | Оперативная реконструкция источника для электроэнцефалографии/магнетоэнцефалографии и электрокардиографии/магнетокардиографии |
CA2563817C (en) * | 2004-04-23 | 2018-07-10 | Yoram Palti | Treating a tumor or the like with electric fields at different frequencies |
EP2364748B1 (en) * | 2004-12-07 | 2018-01-24 | Novocure Limited | Electrodes for applying an electric field in-vivo over an extended period of time |
US20070021803A1 (en) | 2005-07-22 | 2007-01-25 | The Foundry Inc. | Systems and methods for neuromodulation for treatment of pain and other disorders associated with nerve conduction |
WO2007039799A2 (en) * | 2005-10-03 | 2007-04-12 | Novocure Ltd. | Optimizing characteristics of an electric field to increase the field's effect on proliferating cells |
US8019414B2 (en) | 2006-04-05 | 2011-09-13 | Novocure Ltd. | Treating cancer using electromagnetic fields in combination with other treatment regimens |
WO2008034100A2 (en) * | 2006-09-14 | 2008-03-20 | Lazure Technologies, Llc | Ablation probe with deployable electrodes |
US8465533B2 (en) * | 2007-03-06 | 2013-06-18 | Novocure Limited | Treating cancer using electromagnetic fields in combination with photodynamic therapy |
CA2696352C (en) * | 2007-08-14 | 2017-03-21 | Novocure Limited | Treating parasites with electric fields |
EP2197533B1 (en) * | 2007-09-14 | 2015-04-01 | Lazure Technologies, LLC | Prostate cancer ablation |
US20090076500A1 (en) * | 2007-09-14 | 2009-03-19 | Lazure Technologies, Llc | Multi-tine probe and treatment by activation of opposing tines |
WO2009036457A1 (en) | 2007-09-14 | 2009-03-19 | Lazure Technologies, Llc | Multi-layer electrode ablation probe and related methods |
DE102008013827A1 (de) * | 2008-03-12 | 2009-10-01 | Hans-Ulrich Dr. May | Behandlungsvorrichtung für Tiere |
US20100100093A1 (en) * | 2008-09-16 | 2010-04-22 | Lazure Technologies, Llc. | System and method for controlled tissue heating for destruction of cancerous cells |
US8652129B2 (en) | 2008-12-31 | 2014-02-18 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation |
WO2010080886A1 (en) | 2009-01-09 | 2010-07-15 | Recor Medical, Inc. | Methods and apparatus for treatment of mitral valve in insufficiency |
US8728139B2 (en) | 2009-04-16 | 2014-05-20 | Lazure Technologies, Llc | System and method for energy delivery to a tissue using an electrode array |
US9526911B1 (en) | 2010-04-27 | 2016-12-27 | Lazure Scientific, Inc. | Immune mediated cancer cell destruction, systems and methods |
JP6046041B2 (ja) | 2010-10-25 | 2016-12-14 | メドトロニック アーディアン ルクセンブルク ソシエテ ア レスポンサビリテ リミテ | 神経変調療法の評価及びフィードバックのためのデバイス、システム、及び方法 |
US9877781B2 (en) | 2010-11-19 | 2018-01-30 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Electrode catheter device with indifferent electrode for direct current tissue therapies |
US8684901B1 (en) | 2010-11-22 | 2014-04-01 | Jacob Zabara | Electromagnetic radiation treatment for cancer and pathological genetic regulations |
US9233257B1 (en) | 2010-11-22 | 2016-01-12 | Jacob Zabara | Electromagnetic radiation treatment |
US9031701B2 (en) | 2011-02-15 | 2015-05-12 | Hemosonics Llc | Characterization of blood hemostasis and oxygen transport parameters |
US8756792B2 (en) * | 2011-06-08 | 2014-06-24 | The Boeing Company | Digitally designed shims for joining parts of an assembly |
US9750568B2 (en) | 2012-03-08 | 2017-09-05 | Medtronic Ardian Luxembourg S.A.R.L. | Ovarian neuromodulation and associated systems and methods |
US9510777B2 (en) | 2012-03-08 | 2016-12-06 | Medtronic Ardian Luxembourg S.A.R.L. | Monitoring of neuromodulation using biomarkers |
US20140110296A1 (en) | 2012-10-19 | 2014-04-24 | Medtronic Ardian Luxembourg S.A.R.L. | Packaging for Catheter Treatment Devices and Associated Devices, Systems, and Methods |
CN103908744A (zh) * | 2013-01-06 | 2014-07-09 | 张涛 | 一种低强度电流电场癌症治疗设备及方法 |
US10779875B2 (en) | 2013-05-06 | 2020-09-22 | Novocure Gmbh | Optimizing treatment using TTfields by changing the frequency during the course of long term tumor treatment |
US9655669B2 (en) | 2013-05-06 | 2017-05-23 | Novocure Limited | Optimizing treatment using TTFields by changing the frequency during the course of long term tumor treatment |
US10194979B1 (en) | 2014-03-28 | 2019-02-05 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
US10194980B1 (en) | 2014-03-28 | 2019-02-05 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
US9980766B1 (en) | 2014-03-28 | 2018-05-29 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and systems for renal neuromodulation |
CN105476081A (zh) * | 2015-02-12 | 2016-04-13 | 北京至感传感器技术研究院有限公司 | 胸罩组件 |
US9726647B2 (en) | 2015-03-17 | 2017-08-08 | Hemosonics, Llc | Determining mechanical properties via ultrasound-induced resonance |
CN104984479B (zh) * | 2015-05-15 | 2017-10-17 | 陈初生 | 电子对撞对异性细胞的抑制系统及抑制方法 |
US10188851B2 (en) | 2015-10-28 | 2019-01-29 | Novocure Limited | TTField treatment with optimization of electrode positions on the head based on MRI-based conductivity measurements |
US10275565B2 (en) | 2015-11-06 | 2019-04-30 | The Boeing Company | Advanced automated process for the wing-to-body join of an aircraft with predictive surface scanning |
US10521551B2 (en) | 2015-11-16 | 2019-12-31 | The Boeing Company | Methods for shimming flexible bodies |
US10821283B2 (en) | 2016-04-04 | 2020-11-03 | Novocure Gmbh | Reducing motility of cancer cells using tumor treating fields (TTFields) |
CA3029468A1 (en) * | 2016-06-30 | 2018-01-04 | Zeev Bomzon | Arrays for longitudinal delivery of ttfields to a body |
CN110178029B (zh) | 2017-01-19 | 2021-11-16 | 诺沃库勒有限责任公司 | 用于在施加TTFields的同时在显微镜下观察细胞培养物的系统 |
CN106823145A (zh) * | 2017-03-24 | 2017-06-13 | 长沙普特斯科技有限公司 | 一种采用调幅电场治疗肿瘤的装置 |
CN106823125A (zh) * | 2017-03-24 | 2017-06-13 | 长沙利星医药科技开发有限公司 | 一种采用调幅电场增强药物疗效的装置 |
CN107362445A (zh) * | 2017-08-30 | 2017-11-21 | 东北师范大学 | 抗癌靶向药物指向静电场合成矢量增强装置 |
CN109432601A (zh) * | 2017-10-20 | 2019-03-08 | 湖南安泰康成生物科技有限公司 | 用于破坏和抑制患者体内病变组织快速生长的设备 |
CN107981860B (zh) * | 2017-12-08 | 2019-12-31 | 浙江大学 | 一种非接触非侵入无损伤的癫痫路径可达方式监测预警干预系统及获取干扰脑电分布的方法 |
CN108158579B (zh) * | 2017-12-08 | 2020-01-21 | 浙江大学 | 一种非接触非侵入无损伤的癫痫自组织监测预警干预系统及获取干扰脑电分布的方法 |
EP4218641A1 (en) | 2017-12-26 | 2023-08-02 | Galvanize Therapeutics, Inc. | Optimization of energy delivery for various applications |
EP3755416A1 (en) | 2018-02-20 | 2020-12-30 | University Of Iowa Research Foundation | Therapeutic systems using magnetic and electric fields |
US11850440B2 (en) | 2019-08-22 | 2023-12-26 | University Of Iowa Research Foundation | Therapeutic systems using magnetic fields |
US10953209B2 (en) | 2018-03-28 | 2021-03-23 | Board Of Regents Of The University Of Texas System | Treating tumors using TTFields combined with a PARP inhibitor |
CN112566665A (zh) | 2018-04-09 | 2021-03-26 | 莫舍·吉拉迪 | 用TTFields和Aurora激酶抑制剂治疗肿瘤 |
PL3775956T3 (pl) | 2018-04-10 | 2022-10-10 | Novocure Gmbh | Szacunki przewodności ac o niskiej częstotliwości (< 1 mhz) pozyskane z dwóch obrazów mri o różnych czasach repetycji |
KR102592927B1 (ko) | 2018-07-03 | 2023-10-20 | 에드윈 창 | 세포막 투과성을 향상시키기 위한 교류 전기장 사용 |
US11179322B2 (en) | 2018-07-10 | 2021-11-23 | Novocure Gmbh | Methods and compositions for treating tumors with TTFields and sorafenib |
WO2020012364A1 (en) | 2018-07-10 | 2020-01-16 | Novocure Gmbh | Inhibiting viral infection using alternating electric fields |
SG11202012567PA (en) | 2018-07-18 | 2021-01-28 | Novocure Gmbh | Using power loss density and related measures to quantify the dose of tumor treating fields (ttfields) |
PL3773291T3 (pl) | 2018-08-23 | 2022-01-31 | Novocure Gmbh | Zastosowanie przemiennych pól elektrycznych do zwiększania przepuszczalności bariery krew-mózg |
US11160977B2 (en) | 2018-09-04 | 2021-11-02 | Novocure Gmbh | Delivering tumor treating fields (TTFields) to the infratentorial brain |
WO2020049482A1 (en) * | 2018-09-07 | 2020-03-12 | Yaniv Alon | Treating autoimmune diseases using an alternating electric field to reduce the proliferation of t-cells |
US10712730B2 (en) | 2018-10-04 | 2020-07-14 | The Boeing Company | Methods of synchronizing manufacturing of a shimless assembly |
EP3840823B1 (en) | 2018-10-15 | 2023-07-12 | Novocure GmbH | Generating tumor treating fields (ttfields) with high uniformity throughout the brain |
CN112955208A (zh) | 2018-10-25 | 2021-06-11 | 吉夫·波姆桑 | 向受试者的脊柱解剖结构递送交变电场(例如,ttfields) |
EP4019080A1 (en) | 2018-11-19 | 2022-06-29 | Novocure GmbH | Arrays for delivering tumor treating fields (ttfields) with selectively addressable sub-elements |
EP4019081B1 (en) | 2018-11-29 | 2024-04-03 | Novocure GmbH | Enhanced-flexibility transducer arrays for delivering ttfields (tumor treating fields) |
CN113330485A (zh) | 2019-01-08 | 2021-08-31 | 诺沃库勒有限责任公司 | 评估将图像分割成不同类型组织的质量,用于使用肿瘤治疗场(TTField)来计划治疗 |
EP3974022B1 (en) | 2019-02-26 | 2024-04-17 | Novocure GmbH | Determining a frequency for ttfields treatment based on a physical parameter of targeted cancer cells |
CN113453638A (zh) | 2019-02-27 | 2021-09-28 | 诺沃库勒有限责任公司 | 使用可植入换能器阵列递送肿瘤治疗场(TTFields) |
CN109717841B (zh) * | 2019-03-12 | 2022-02-22 | 西南医科大学 | 一种皮肤病变内源性电场测量装置及方法 |
EP3988099B1 (en) | 2019-03-29 | 2023-06-07 | Novocure GmbH | Methods for restoring sensitivity to ttfields in ttfields-resistant cancer cells with ptger3 inhibitors |
CN113966243A (zh) | 2019-04-17 | 2022-01-21 | 诺沃库勒有限责任公司 | 在不损害隔离的情况下从隔离的系统上传数据 |
WO2021019403A1 (en) | 2019-07-31 | 2021-02-04 | Yoram Wasserman | Applying tumor treating fields (ttfields) via electrodes embedded into skull implants |
CN114364433A (zh) | 2019-08-30 | 2022-04-15 | 诺沃库勒有限责任公司 | 向颈部输送肿瘤治疗场(TTFields) |
CN112652213B (zh) * | 2019-10-12 | 2022-09-02 | 王宪 | 一种细胞有丝分裂动态模拟教具 |
US20210169568A1 (en) * | 2019-12-09 | 2021-06-10 | Biosense Webster (Israel) Ltd. | Oriented irreversible-electroporation (ire) pulses to compensate for cell size and orientation |
EP4054701A1 (en) | 2019-12-31 | 2022-09-14 | Novocure GmbH | Arrays for delivering tumor treating fields (ttfields) with individually accessible electrode elements and temperature sensors |
US20230147250A1 (en) * | 2019-12-31 | 2023-05-11 | Novocure Gmbh | Methods, systems, and apparatuses for combined tumor treating fields and mental health therapy |
CN114901347A (zh) | 2019-12-31 | 2022-08-12 | 诺沃库勒有限责任公司 | 防止幅度调整和信道切换期间的尖峰的高电压、高效率正弦波生成器 |
EP4168108A1 (en) | 2020-06-19 | 2023-04-26 | The Methodist Hospital dba Houston Methodist Hospital | Method and apparatus for oncomagnetic treatment |
US11818943B2 (en) | 2020-06-25 | 2023-11-14 | Novocure Gmbh | Fabricating organic light emitting diodes (OLEDs) using tubulin |
KR102556846B1 (ko) * | 2020-10-26 | 2023-07-18 | 주식회사 뉴아인 | 비정상 분열 세포에 대한 사멸 유도 장치 및 이의 구동 방법 |
CN112690757B (zh) * | 2020-12-17 | 2022-06-14 | 成都柔电云科科技有限公司 | 压力性损伤监测及反馈设备、反馈调节系统 |
CN112834573A (zh) * | 2020-12-30 | 2021-05-25 | 武汉大学 | 一种中频微电场生物效应快速试验方法 |
CN113122448A (zh) * | 2021-04-12 | 2021-07-16 | 深圳市第二人民医院(深圳市转化医学研究院) | 一种用于细胞培养的非接触电场装置及其细胞培养方法 |
CN113005037A (zh) * | 2021-04-12 | 2021-06-22 | 深圳市第二人民医院(深圳市转化医学研究院) | 一种用于细胞培养的电极绝缘垫及其非接触电场装置和方法 |
CN113476746A (zh) * | 2021-07-20 | 2021-10-08 | 杭州维纳安可医疗科技有限责任公司 | 抑制病变细胞分裂的设备、控制方法及控制装置 |
CN113616922A (zh) * | 2021-07-20 | 2021-11-09 | 杭州维纳安可医疗科技有限责任公司 | 目标电场的发生装置及控制方法 |
CN113546316A (zh) * | 2021-07-26 | 2021-10-26 | 昆仑智鼎(北京)医疗技术有限公司 | 三维磁环的交变电场装置 |
CN113546322A (zh) * | 2021-07-26 | 2021-10-26 | 昆仑智鼎(北京)医疗技术有限公司 | 治疗用三维磁环装置及其应用 |
CN113521542A (zh) * | 2021-07-26 | 2021-10-22 | 昆仑智鼎(北京)医疗技术有限公司 | 一种治疗用磁环阵列装置 |
CN113577562A (zh) * | 2021-07-26 | 2021-11-02 | 昆仑智鼎(北京)医疗技术有限公司 | 用于选择性破坏或抑制肿瘤细胞有丝分裂的交变电场装置 |
CN113521543A (zh) * | 2021-07-26 | 2021-10-22 | 昆仑智鼎(北京)医疗技术有限公司 | 磁环阵列治疗装置 |
CN113521541A (zh) * | 2021-07-26 | 2021-10-22 | 昆仑智鼎(北京)医疗技术有限公司 | 用于选择性破坏或抑制肿瘤细胞有丝分裂的装置 |
CN113546323A (zh) * | 2021-07-26 | 2021-10-26 | 昆仑智鼎(北京)医疗技术有限公司 | 治疗用磁环阵列装置 |
CN113667599A (zh) * | 2021-08-19 | 2021-11-19 | 杭州维纳安可医疗科技有限责任公司 | 抑制细菌增殖的系统及其控制方法 |
CN114099961A (zh) * | 2021-12-22 | 2022-03-01 | 江苏海莱新创医疗科技有限公司 | 电极贴片的贴敷方法 |
CN114534091B (zh) * | 2022-02-17 | 2022-09-09 | 湖南安泰康成生物科技有限公司 | 利用电场抑制肿瘤增殖的设备及其控制装置 |
US20240001111A1 (en) * | 2022-06-30 | 2024-01-04 | Novocure Gmbh | Electrode Assembly for Applying Tumor Treating Fields (TTFields) that Includes a Plurality of Thermally Linked but Electrically Isolated Graphite Sheets |
US20240108888A1 (en) * | 2022-09-30 | 2024-04-04 | Novocure Gmbh | Reducing Electrosensation While Treating a Subject Using Alternating Electric Fields by Controlling Ramp-Up Characteristics |
US20240108892A1 (en) | 2022-09-30 | 2024-04-04 | Novocure Gmbh | Changing the Orientation of Tumor Treating Fields (TTFields) by Adjusting the Amplitudes of Two or More Electric Fields that Are All In-Phase with Each Other |
CN115779273A (zh) * | 2022-11-03 | 2023-03-14 | 赛福凯尔(绍兴)医疗科技有限公司 | 电场能量聚焦的发射装置及方法 |
CN116196554B (zh) * | 2023-03-23 | 2024-03-12 | 湖南安泰康成生物科技有限公司 | 一种使用多个电场覆盖肿瘤细胞敏感频率以治疗肿瘤的系统 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1138829A (zh) * | 1994-01-24 | 1996-12-25 | 麦德托尼克公司 | 用于硬膜外脊髓刺激的多道设备 |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR446660A (fr) | 1911-09-02 | 1912-12-12 | Gottlieb Schuettel | Dispositif pour métiers continus à anneaux pour monter les curseurs sur les anneaux |
US3991770A (en) | 1974-01-24 | 1976-11-16 | Leveen Harry H | Method for treating benign and malignant tumors utilizing radio frequency, electromagnetic radiation |
JPS5134585A (ja) * | 1974-09-18 | 1976-03-24 | Katsuzo Ishige | Koshuhairyoki |
US4016886A (en) | 1974-11-26 | 1977-04-12 | The United States Of America As Represented By The United States Energy Research And Development Administration | Method for localizing heating in tumor tissue |
US4121592A (en) | 1975-08-04 | 1978-10-24 | Critical Systems, Inc. | Apparatus for heating tissue |
DE2813068A1 (de) | 1978-03-25 | 1979-10-04 | Philips Patentverwaltung | Verfahren und vorrichtung zur ermittlung von inneren koerperstrukturen |
US4346715A (en) * | 1978-07-12 | 1982-08-31 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Hyperthermia heating apparatus |
US4472506A (en) | 1981-01-13 | 1984-09-18 | Liburdy Robert P | Method for determining cell membrane dielectric breakdown |
US4467809A (en) | 1982-09-17 | 1984-08-28 | Biolectron, Inc. | Method for non-invasive electrical stimulation of epiphyseal plate growth |
US4622952A (en) | 1983-01-13 | 1986-11-18 | Gordon Robert T | Cancer treatment method |
CA1244889A (en) | 1983-01-24 | 1988-11-15 | Kureha Chemical Ind Co Ltd | HYPERTHERMIA DEVICE |
DE3323415C2 (de) | 1983-06-29 | 1985-04-25 | Kernforschungsanlage Jülich GmbH, 5170 Jülich | Verwendung eines Verfahrens und einer Vorrichtung zur Bestimmung von Zellinhaltstoffe sezernierenden Zellen |
SE455920B (sv) | 1986-01-29 | 1988-08-22 | Hans Wiksell | Anordning for hypertermibehandling av tumorer |
US4923814A (en) | 1986-05-09 | 1990-05-08 | Electropore, Inc. | High speed, high power apparatus for vesicle prealignment, poration, loading and fusion in uniform electric fields and method therefor |
CN86103803B (zh) | 1986-06-05 | 1987-11-18 | 北京信息工程学院 | 静电场治疗装置 |
US4822470A (en) | 1987-10-09 | 1989-04-18 | Baylor College Of Medicine | Method of and apparatus for cell poration and cell fusion using radiofrequency electrical pulses |
US4936303A (en) | 1987-11-20 | 1990-06-26 | Ultrathermics | Ultrasonic heating apparatus and method |
JPH0629196B2 (ja) | 1987-12-01 | 1994-04-20 | 甲子郎 梅村 | 超音波による腫瘍治療用生理作用増強剤 |
US5389069A (en) | 1988-01-21 | 1995-02-14 | Massachusetts Institute Of Technology | Method and apparatus for in vivo electroporation of remote cells and tissue |
FR2627987B3 (fr) | 1988-03-04 | 1990-02-02 | Indiba Sa | Appareil electronique pour la therapie medicale et cosmetique |
US5158071A (en) | 1988-07-01 | 1992-10-27 | Hitachi, Ltd. | Ultrasonic apparatus for therapeutical use |
JPH0265876A (ja) * | 1988-08-31 | 1990-03-06 | Shimadzu Corp | キャビティ型ハイパーサーミア装置 |
GB8904998D0 (en) | 1989-03-04 | 1989-04-19 | Matthews Tony | Anaesthetising apparatus |
US5099756A (en) | 1989-06-01 | 1992-03-31 | Harry H. Leveen | Radio frequency thermotherapy |
JP2643457B2 (ja) * | 1989-06-28 | 1997-08-20 | 三菱電機株式会社 | プラズマ処理装置及びその方法 |
US5441746A (en) | 1989-12-22 | 1995-08-15 | Molecular Bioquest, Inc. | Electromagnetic wave absorbing, surface modified magnetic particles for use in medical applications, and their method of production |
US5236410A (en) | 1990-08-02 | 1993-08-17 | Ferrotherm International, Inc. | Tumor treatment method |
WO1992019286A1 (en) | 1991-05-03 | 1992-11-12 | University Technologies International, Inc. | Biofilm reduction method |
US5441532A (en) | 1991-06-26 | 1995-08-15 | Massachusetts Institute Of Technology | Adaptive focusing and nulling hyperthermia annular and monopole phased array applicators |
US5683366A (en) * | 1992-01-07 | 1997-11-04 | Arthrocare Corporation | System and method for electrosurgical tissue canalization |
US5468223A (en) | 1992-11-30 | 1995-11-21 | C.N.R.S. Paris | Electrochemotherapy |
US5386837A (en) | 1993-02-01 | 1995-02-07 | Mmtc, Inc. | Method for enhancing delivery of chemotherapy employing high-frequency force fields |
JPH06242269A (ja) * | 1993-02-19 | 1994-09-02 | Yokogawa Electric Corp | 超音波メータ |
FR2703253B1 (fr) * | 1993-03-30 | 1995-06-23 | Centre Nat Rech Scient | Applicateur d'impulsions electriques pour traitement de tissus biologiques. |
IL108775A (en) | 1994-02-25 | 2003-09-17 | Univ Ramot | Method for efficient incorporation of molecules into cells |
US5704355A (en) | 1994-07-01 | 1998-01-06 | Bridges; Jack E. | Non-invasive system for breast cancer detection |
WO1997004830A1 (en) | 1995-07-28 | 1997-02-13 | Gray James R | Use of a polarizing field to modify the efficacy of a bioactive agent |
US5606971A (en) | 1995-11-13 | 1997-03-04 | Artann Corporation, A Nj Corp. | Method and device for shear wave elasticity imaging |
US5718246A (en) | 1996-01-03 | 1998-02-17 | Preferential, Inc. | Preferential induction of electrically mediated cell death from applied pulses |
US5984882A (en) | 1996-08-19 | 1999-11-16 | Angiosonics Inc. | Methods for prevention and treatment of cancer and other proliferative diseases with ultrasonic energy |
US5869326A (en) | 1996-09-09 | 1999-02-09 | Genetronics, Inc. | Electroporation employing user-configured pulsing scheme |
US6055453A (en) | 1997-08-01 | 2000-04-25 | Genetronics, Inc. | Apparatus for addressing needle array electrodes for electroporation therapy |
US6241701B1 (en) * | 1997-08-01 | 2001-06-05 | Genetronics, Inc. | Apparatus for electroporation mediated delivery of drugs and genes |
EP1003847A4 (en) | 1997-09-04 | 2005-04-06 | Science Res Lab Inc | SEPARATION OF CELLS BY USE OF ELECTRIC FIELDS |
US6027488A (en) | 1998-06-03 | 2000-02-22 | Genetronics, Inc. | Flow-through electroporation system for ex vivo gene therapy |
US5976092A (en) | 1998-06-15 | 1999-11-02 | Chinn; Douglas O. | Combination stereotactic surgical guide and ultrasonic probe |
US6319901B1 (en) | 1998-10-15 | 2001-11-20 | Ichor Medical Systems, Inc. | Methods for prolonging cell membrane permeability |
JP4102031B2 (ja) | 1999-03-09 | 2008-06-18 | サーメイジ インコーポレイテッド | 組織を治療するのための装置および方法 |
US6678558B1 (en) | 1999-03-25 | 2004-01-13 | Genetronics, Inc. | Method and apparatus for reducing electroporation-mediated muscle reaction and pain response |
US6366808B1 (en) | 2000-03-13 | 2002-04-02 | Edward A. Schroeppel | Implantable device and method for the electrical treatment of cancer |
US6853864B2 (en) | 2000-02-02 | 2005-02-08 | Catholic University Of America, The | Use of electromagnetic fields in cancer and other therapies |
CN1416466A (zh) | 2000-02-17 | 2003-05-07 | 约朗姆·帕尔蒂 | 破坏正在分裂的细胞的方法和装置 |
US7016725B2 (en) * | 2001-11-06 | 2006-03-21 | Standen Ltd. | Method and apparatus for destroying dividing cells |
US7146210B2 (en) * | 2000-02-17 | 2006-12-05 | Standen Ltd. | Apparatus and method for optimizing tumor treatment efficiency by electric fields |
US6868289B2 (en) * | 2002-10-02 | 2005-03-15 | Standen Ltd. | Apparatus for treating a tumor or the like and articles incorporating the apparatus for treatment of the tumor |
US6546290B1 (en) | 2000-04-12 | 2003-04-08 | Roamitron Holding S.A. | Method and apparatus for electromedical therapy |
KR20020074599A (ko) * | 2001-03-20 | 2002-10-04 | 서동학 | 열변색 고분자 수화겔(thermochromic polymer hydrogel)조성물 및 그의 제조방법 |
US7083580B2 (en) * | 2001-04-06 | 2006-08-01 | Mattioli Engineering Ltd. | Method and apparatus for skin absorption enhancement and transdermal drug delivery |
US6994706B2 (en) | 2001-08-13 | 2006-02-07 | Minnesota Medical Physics, Llc | Apparatus and method for treatment of benign prostatic hyperplasia |
CA2563817C (en) * | 2004-04-23 | 2018-07-10 | Yoram Palti | Treating a tumor or the like with electric fields at different frequencies |
EP2364748B1 (en) | 2004-12-07 | 2018-01-24 | Novocure Limited | Electrodes for applying an electric field in-vivo over an extended period of time |
-
2005
- 2005-12-27 US US11/318,702 patent/US7565206B2/en not_active Expired - Lifetime
- 2005-12-27 CN CN200580048335XA patent/CN101124011B/zh active Active
- 2005-12-27 EP EP20152897.3A patent/EP3666328B1/en active Active
- 2005-12-27 EP EP05856273A patent/EP1833554A2/en not_active Ceased
- 2005-12-27 CA CA2594231A patent/CA2594231C/en active Active
- 2005-12-27 JP JP2007547714A patent/JP5559460B2/ja active Active
- 2005-12-27 WO PCT/IB2005/004169 patent/WO2006085150A2/en active Application Filing
- 2005-12-27 CN CN201110226148.3A patent/CN102488967B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1138829A (zh) * | 1994-01-24 | 1996-12-25 | 麦德托尼克公司 | 用于硬膜外脊髓刺激的多道设备 |
Also Published As
Publication number | Publication date |
---|---|
CN101124011B (zh) | 2011-08-31 |
US20060167499A1 (en) | 2006-07-27 |
WO2006085150A2 (en) | 2006-08-17 |
JP5559460B2 (ja) | 2014-07-23 |
CA2594231C (en) | 2016-04-19 |
CA2594231A1 (en) | 2006-08-17 |
EP1833554A2 (en) | 2007-09-19 |
US7565206B2 (en) | 2009-07-21 |
JP2008525080A (ja) | 2008-07-17 |
CN102488967A (zh) | 2012-06-13 |
EP3666328A1 (en) | 2020-06-17 |
EP3666328B1 (en) | 2022-04-06 |
CN101124011A (zh) | 2008-02-13 |
WO2006085150A3 (en) | 2006-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102488967B (zh) | 利用电场从不同方向治疗肿瘤等 | |
JP4750784B2 (ja) | 異なる周波数の電界による腫瘍等の治療 | |
JP4350042B2 (ja) | 腫瘍等を治療するための装置ならびに腫瘍の治療のための装置を備えた製品 | |
US7089054B2 (en) | Apparatus and method for treating a tumor or the like | |
CA2697012C (en) | Treating bacteria with electric fields | |
CA2696352C (en) | Treating parasites with electric fields |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: British Jersey Applicant after: Novocure Ltd. Address before: British Jersey Applicant before: Standen Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: STANDEN LTD. TO: STADEN LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120613 Assignee: Novocure Ltd. Assignor: Novocure Ltd. Contract record no.: 2019990000116 Denomination of invention: Treating a tumor or the like with electric fields at different orientations Granted publication date: 20160330 License type: Common License Record date: 20190412 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200930 Address after: Luzern, Switzerland Patentee after: Novokule Co., Ltd Address before: British West Patentee before: NOVOCURE Ltd. |